Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Chinese install second BSD Medical clinical hyperthermia unit

BSD Medical : 12 June, 2007  (New Product)
A second BSD Medical BSD-2000 cancer treatment system has been purchased and installed in China, at the Shanzi Coal Center Hospital located in Taiyuan City, Shanxi Province.
This 800 bed hospital, which treats over 100,000 people yearly in its outpatient programme alone, was founded in 1983 and is one of the most distinguished hospitals in Shanxi Province.

Dalian Orientech, BSD Medical's Chinese Distributor, is continuing to target prestigious hospitals for its installations, allowing the BSD-2000 to have visible exposure to the broader Chinese market.

China is rapidly evolving into one of the world's largest markets for high-technology medical equipment.

It has also been an early adaptor in the use of clinical hyperthermia in the treatment of cancer, and has several thousand simple hyperthermia cancer therapy systems in place.

The market objective in China is to continue to expand and upgrade the existing market for clinical hyperthermia equipment to the advanced features of the BSD-2000.

The BSD-2000 delivers precision focused RF energy into cancerous tumours, including those located deep in the body, raising the tumour temperature to levels required to administer hyperthermia therapy in order to destroy cancer cells with heat and increase the effectiveness of radiation therapy.

Research has also shown promising results from the use of hyperthermia therapy in combination with some chemotherapy agents, and for tumour reduction prior to surgery.

A 340 patient Phase III clinical trial presented last week in Chicago at the American Society of Clinical Oncology (ASCO) conference reported a near doubling of disease-free survival for high-risk sarcoma patients who were treated with chemotherapy and hyperthermia therapy, as compared to those who were treated with chemotherapy alone.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo